Dendrimer Prodrugs
The main objective of this review is to describe the importance of dendrimer prodrugs in the design of new drugs, presenting numerous applications of these nanocomposites in the pharmaceutical field. Therefore, the use of dendrimer prodrugs as carrier for drug delivery, to improve pharmacokinetic pr...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-05-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/21/6/686 |
id |
doaj-018293896c1a45b7a3a4949997578b15 |
---|---|
record_format |
Article |
spelling |
doaj-018293896c1a45b7a3a4949997578b152020-11-24T21:12:09ZengMDPI AGMolecules1420-30492016-05-0121668610.3390/molecules21060686molecules21060686Dendrimer ProdrugsSoraya da Silva Santos0Elizabeth Igne Ferreira1Jeanine Giarolla2Laboratory of Design and Synthesis of Chemotherapeutics Potentially Active in Neglected Diseases (LAPEN), Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo—USP, Avenue Professor Lineu Prestes, 580–Building 13, São Paulo SP, 05508-900, BrazilLaboratory of Design and Synthesis of Chemotherapeutics Potentially Active in Neglected Diseases (LAPEN), Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo—USP, Avenue Professor Lineu Prestes, 580–Building 13, São Paulo SP, 05508-900, BrazilLaboratory of Design and Synthesis of Chemotherapeutics Potentially Active in Neglected Diseases (LAPEN), Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo—USP, Avenue Professor Lineu Prestes, 580–Building 13, São Paulo SP, 05508-900, BrazilThe main objective of this review is to describe the importance of dendrimer prodrugs in the design of new drugs, presenting numerous applications of these nanocomposites in the pharmaceutical field. Therefore, the use of dendrimer prodrugs as carrier for drug delivery, to improve pharmacokinetic properties of prototype, to promote drug sustained-release, to increase selectivity and, consequently, to decrease toxicity, are just some examples of topics that have been extensively reported in the literature, especially in the last decade. The examples discussed here give a panel of the growing interest dendrimer prodrugs have been evoking in the scientific community.http://www.mdpi.com/1420-3049/21/6/686dendrimerprodrugsmolecular modificationstargeted dendrimerpharmaceutical applications |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Soraya da Silva Santos Elizabeth Igne Ferreira Jeanine Giarolla |
spellingShingle |
Soraya da Silva Santos Elizabeth Igne Ferreira Jeanine Giarolla Dendrimer Prodrugs Molecules dendrimer prodrugs molecular modifications targeted dendrimer pharmaceutical applications |
author_facet |
Soraya da Silva Santos Elizabeth Igne Ferreira Jeanine Giarolla |
author_sort |
Soraya da Silva Santos |
title |
Dendrimer Prodrugs |
title_short |
Dendrimer Prodrugs |
title_full |
Dendrimer Prodrugs |
title_fullStr |
Dendrimer Prodrugs |
title_full_unstemmed |
Dendrimer Prodrugs |
title_sort |
dendrimer prodrugs |
publisher |
MDPI AG |
series |
Molecules |
issn |
1420-3049 |
publishDate |
2016-05-01 |
description |
The main objective of this review is to describe the importance of dendrimer prodrugs in the design of new drugs, presenting numerous applications of these nanocomposites in the pharmaceutical field. Therefore, the use of dendrimer prodrugs as carrier for drug delivery, to improve pharmacokinetic properties of prototype, to promote drug sustained-release, to increase selectivity and, consequently, to decrease toxicity, are just some examples of topics that have been extensively reported in the literature, especially in the last decade. The examples discussed here give a panel of the growing interest dendrimer prodrugs have been evoking in the scientific community. |
topic |
dendrimer prodrugs molecular modifications targeted dendrimer pharmaceutical applications |
url |
http://www.mdpi.com/1420-3049/21/6/686 |
work_keys_str_mv |
AT sorayadasilvasantos dendrimerprodrugs AT elizabethigneferreira dendrimerprodrugs AT jeaninegiarolla dendrimerprodrugs |
_version_ |
1716751420072394752 |